Marex Group’s Eli Lilly LLY Stock Holding History

Marex Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$134M	Buy	145,674 +111,003	+320%	+$113M	0.85%	31
2025 Q4	$37.3M	Sell	34,671 -338,743	-91%	-$324M	0.23%	93
2025 Q3	$285M	Buy	373,414 +89,007	+31%	+$66.2M	2.01%	14
2025 Q2	$222M	Buy	284,407 +83,306	+41%	+$64.7M	1.92%	9
2025 Q1	$166M	Sell	201,101 -22,634	-10%	-$18.8M	3.18%	7
2024 Q4	$173M	Buy	223,735 +75,508	+51%	+$62.5M	2.94%	10
2024 Q3	$131M	Sell	148,227 -10,250	-6%	-$9.22M	3%	9
2024 Q2	$143M	Buy	158,477 +4,035	+3%	+$3.23M	3.85%	6
2024 Q1	$120M	Buy	154,442 +106,352	+221%	+$75.7M	3.9%	4
2023 Q4	$28M	Buy	48,090 +47,331	+6,236%	+$27.6M	1.1%	15
2023 Q3	$408K	Buy	759 +283	+59%	+$146K	0.06%	129
2023 Q2	$223K	Buy	+476	New	+$200K	0.04%	191
2023 Q1	–	Sell	-600	Closed	-$220K	–	296
2022 Q4	$220K	Buy	+600	New	+$213K	0.03%	227

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marex Group's LLY Position: Q1 2026 in Review

Marex Group increased its Eli Lilly (LLY) stake by 320% in Q1 2026, buying an estimated $113M and bringing the position to 145,674 shares worth $134M. The position accounts for 0.85% of the portfolio, ranked #31.

Marex Group first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $285M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Marex Group held 145,674 shares of Eli Lilly worth $134M as of Q1 2026.
Marex Group bought 111,003 Eli Lilly shares in Q1 2026, an estimated $113M.
Eli Lilly made up 0.85% of Marex Group's portfolio in Q1 2026, its #31 holding.
Marex Group first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
Marex Group's Eli Lilly position peaked at $285M in Q3 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.